PMC:7200337 / 94044-94249 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T735","span":{"begin":57,"end":70},"obj":"Body_part"}],"attributes":[{"id":"A735","pred":"fma_id","subj":"T735","obj":"http://purl.org/sig/ont/fma/fma9825"}],"text":"While vaccines are being developed to educate a person’s immune system to make their own nAbs against SARS-CoV-2, there is interest in using adoptive transfer of nAbs as a therapeutic approach (Figure 6D)."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T97","span":{"begin":57,"end":70},"obj":"Body_part"}],"attributes":[{"id":"A97","pred":"uberon_id","subj":"T97","obj":"http://purl.obolibrary.org/obo/UBERON_0002405"}],"text":"While vaccines are being developed to educate a person’s immune system to make their own nAbs against SARS-CoV-2, there is interest in using adoptive transfer of nAbs as a therapeutic approach (Figure 6D)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T537","span":{"begin":102,"end":110},"obj":"Disease"}],"attributes":[{"id":"A537","pred":"mondo_id","subj":"T537","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"While vaccines are being developed to educate a person’s immune system to make their own nAbs against SARS-CoV-2, there is interest in using adoptive transfer of nAbs as a therapeutic approach (Figure 6D)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T969","span":{"begin":46,"end":47},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T970","span":{"begin":57,"end":70},"obj":"http://purl.obolibrary.org/obo/UBERON_0002405"},{"id":"T971","span":{"begin":170,"end":171},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"While vaccines are being developed to educate a person’s immune system to make their own nAbs against SARS-CoV-2, there is interest in using adoptive transfer of nAbs as a therapeutic approach (Figure 6D)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3093","span":{"begin":71,"end":73},"obj":"Gene"},{"id":"3094","span":{"begin":35,"end":37},"obj":"Gene"},{"id":"3095","span":{"begin":102,"end":112},"obj":"Species"},{"id":"3099","span":{"begin":89,"end":93},"obj":"Chemical"},{"id":"3100","span":{"begin":162,"end":166},"obj":"Chemical"}],"attributes":[{"id":"A3093","pred":"tao:has_database_id","subj":"3093","obj":"Gene:6999"},{"id":"A3094","pred":"tao:has_database_id","subj":"3094","obj":"Gene:6999"},{"id":"A3095","pred":"tao:has_database_id","subj":"3095","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"While vaccines are being developed to educate a person’s immune system to make their own nAbs against SARS-CoV-2, there is interest in using adoptive transfer of nAbs as a therapeutic approach (Figure 6D)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T541","span":{"begin":0,"end":205},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"While vaccines are being developed to educate a person’s immune system to make their own nAbs against SARS-CoV-2, there is interest in using adoptive transfer of nAbs as a therapeutic approach (Figure 6D)."}